#news #biotech Aslan fails to roar as lead drug flunks phase 2 trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Aslan fails to roar as lead drug flunks phase 2 trial .Aslan Pharmaceuticals has been hit by the news that its lead drug varlitinib missed the mark in a gastric cancer trial, sending its shares down almost 16%.

from FierceBiotech: Biotech http://bit.ly/2VSkFZ6